In March 2025, the company introduced new ideas for the immediate-to-consumer supplying of its Wegovy weight loss drug. The company established a new pharmacy, referred to as NovoCare, which would charge clients $499 per month for use of the drug, a lot less than half the expense of the drug by means of other pharmaceutical distribution networks.[f